Works matching IS 2160763X AND DT 2018 AND VI 7 AND IP 2

Results: 15

Effects of a Nutritional Protein‐Rich Drink on the Pharmacokinetics of Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide, and Tenofovir Compared With a Standard Meal in Healthy Japanese Male Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 132, doi. 10.1002/cpdd.365

By:

Yamada, Hiroyuki;
Ikushima, Ippei;
Nemoto, Takanori;
Ishikawa, Tomohiro;
Ninomiya, Noriko;
Irie, Shin

Publication type:

Article

In Memoriam: Darrell R. Abernethy 1949–2017.

Published in:

2018

By:

Greenblatt, David J.;
Mager, Donald E.;
Meibohm, Bernd;
Burckart, Gilbert J.

Publication type:

Obituary

Erratum.

Published in:: 2018
Publication type:: Correction Notice

Pharmacokinetics of Diclofenac and Hydroxypropyl‐β‐Cyclodextrin (HPβCD) Following Administration of Injectable HPβCD‐Diclofenac in Subjects With Mild to Moderate Renal Insufficiency or Mild Hepatic Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 110, doi. 10.1002/cpdd.417

By:

Hamilton, Douglas A.;
Ernst, Cynthia C.;
Kramer, William G.;
Madden, Donna;
Lang, Eric;
Liao, Edward;
Lacouture, Peter G.;
Ramaiya, Atulkumar;
Carr, Daniel B.

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 103, doi. 10.1002/cpdd.399
Publication type:: Article

Two Phase 1, Open‐Label, Mass Balance Studies to Determine the Pharmacokinetics of <sup>14</sup>C‐Labeled Isavuconazonium Sulfate in Healthy Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 207, doi. 10.1002/cpdd.376

By:

Townsend, Robert;
Kato, Kota;
Hale, Christine;
Kowalski, Donna;
Lademacher, Christopher;
Yamazaki, Takao;
Akhtar, Shahzad;
Desai, Amit

Publication type:

Article

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 217, doi. 10.1002/cpdd.424

By:

David, Olivier J.;
Berwick, Amy;
Pezous, Nicole;
Lang, Michael;
Tiel‐Wilck, Klaus;
Ziemssen, Tjalf;
Li, Peng;
Hara, Hisanori;
Schmouder, Robert

Publication type:

Article

A Comparison of the Pharmacokinetics of Methylphenidate Extended‐Release Orally Disintegrating Tablets With a Reference Extended‐Release Formulation of Methylphenidate in Healthy Adults.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 151, doi. 10.1002/cpdd.362

By:

Childress, Ann;
Stark, Jeffrey G.;
McMahen, Russ;
Engelking, Dorothy;
Sikes, Carolyn

Publication type:

Article

Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 160, doi. 10.1002/cpdd.361

By:

Weisler, Richard H.;
Stark, Jeffrey G.;
Sikes, Carolyn

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega‐3‐Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single‐Blind, Randomized, Placebo‐Controlled Trial.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 177, doi. 10.1002/cpdd.360

By:

Noda, Yoshinori;
Nilsson, Catarina;
Shimada, Hitoshi;
Kim, Hyosung;
Lundström, Torbjörn;
Yajima, Toshitaka

Publication type:

Article

Single‐ and Multiple‐Dose Pharmacokinetics of Once‐Daily Formulations of Raltegravir.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 196, doi. 10.1002/cpdd.358

By:

Krishna, Rajesh;
Rizk, Matthew L.;
Larson, Patrick;
Schulz, Valerie;
Kesisoglou, Filippos;
Pop, Radu

Publication type:

Article

The Relative Bioavailability of Ibuprofen After Administration With a Novel Soft Chewable Drug Formulation.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 168, doi. 10.1002/cpdd.357

By:

Hattrem, Magnus N.;
Dille, Morten J.;
Seternes, Tore;
Ege, Thorfinn;
Draget, Kurt I.

Publication type:

Article

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 143, doi. 10.1002/cpdd.354

By:

Anderson, Matt S.;
Kosoglou, Teddy;
Statkevich, Paul;
Li, Jing;
Rotonda, Jennifer;
Meehan, Alan G.;
Cutler, David L.

Publication type:

Article

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 188, doi. 10.1002/cpdd.349

By:

Nomoto, Maiko;
Pastino, Gina;
Rege, Bhaskar;
Aluri, Jagadeesh;
Ferry, Jim;
Han, David

Publication type:

Article

Pharmacokinetics of a Novel Anagrelide Extended‐Release Formulation in Healthy Subjects: Food Intake and Comparison With a Reference Product.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 2, p. 123, doi. 10.1002/cpdd.340

By:

Petrides, Petro E.;
Schoergenhofer, Christian;
Widmann, Rudolf;
Jilma, Bernd;
Klade, Christoph S.

Publication type:

Article